Home » MERCK TO ACQUIRE TWO BIOTECHNOLOGY FIRMS FOR $480MN
MERCK TO ACQUIRE TWO BIOTECHNOLOGY FIRMS FOR $480MN
Pharmaceutical company Merck & Co Inc Tuesday announced that it has agreed to acquire two biotechnology companies, GlycoFi Inc and Abmaxis Inc, for a total consideration of $480 million.
Newratings
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May